Complex lipid metabolic remodeling is required for efficient hepatitis C virus replication.

Hepatitis C virus (HCV) relies on host cell lipid metabolism for replication. It is known that HCV uses the endoplasmic reticulum and lipid droplets for replication and assembly. However, the precise changes in lipid composition during infection remain unclear. Prior studies have shown that HCV alters lipid environments, but the full extent of these changes has not been fully mapped. This gap motivated researchers to investigate the specific lipidomic shifts in HCV-infected cells. No prior work had resolved how different lipid classes are affected or how these changes support viral replication. This uncertainty drove the use of quantitative lipidomic methods to explore these alterations in detail. The study aimed to clarify whether HCV induces a broad metabolic reprogramming of host lipids. Understanding these changes could help identify new therapeutic targets. The current work builds on existing knowledge of HCV and lipid interactions.

The study aimed to determine how HCV infection alters the lipid composition of host cells and subcellular compartments. Researchers focused on identifying specific lipid classes affected by the virus. They sought to understand whether changes in lipid metabolism are necessary for HCV replication. The goal was to uncover whether HCV induces a complex lipid remodeling process. The study also aimed to test whether specific lipid components are essential for viral replication. Researchers hypothesized that HCV may alter fatty acid chain lengths and lipid types to support its life cycle. The work was designed to test whether lipid metabolism is a targetable aspect of HCV infection. The findings could inform new strategies for antiviral therapies.

Researchers used quantitative shotgun lipidomics to profile lipid changes in HCV-infected cells. They analyzed whole cell extracts and isolated subcellular compartments. The study focused on neutral and membrane lipid ratios in infected versus uninfected cells. Specific lipid classes, including cholesterol and phospholipids, were quantified. The team also examined fatty acid chain lengths in phosphatidylcholines and triglycerides. They assessed the role of fatty acid elongases and desaturases in HCV replication. Free fatty acid levels were measured to detect changes in polyunsaturated fatty acids (PUFAs). The study tested the effect of Δ6-desaturase inhibition on viral progeny production.

HCV infection reduced the neutral to membrane lipid ratio without changing lipid droplet morphology. Membrane lipids, particularly cholesterol and phospholipids, accumulated in the microsomal fraction. Infected cells showed increased phosphatidylcholines and triglycerides with longer fatty acyl chains. The virus preferentially used C18 fatty acids, especially oleic acid (FA [18:1]). Depletion of fatty acid elongases and desaturases impaired HCV replication. Polyunsaturated fatty acid (PUFA) levels increased in infected cells. Knockdown of Δ6-desaturase reduced viral progeny production. Low-dose PUFA synthesis inhibitors promoted HCV translation or early RNA replication.

The study demonstrates that HCV induces complex lipid metabolic remodeling in host cells. This remodeling supports both viral replication and progeny production. The virus alters lipid composition by increasing membrane lipids and specific fatty acid chain lengths. Elevated PUFAs appear necessary for virion morphogenesis. The findings suggest that lipid metabolism is a key factor in HCV life cycle. The role of C18 fatty acids, especially oleic acid, is highlighted as significant. Inhibition of PUFA synthesis pathways can impair viral replication. These results align with the authors' claim that lipid metabolism is reprogrammed to enhance HCV infection.